Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City

Fig. 3

Kaplan–Meier curve assessing the effect of vaccination in incident cases. Only individuals with SARS-CoV-2 negative test in sample 1 were included in the analysis. Follow-up time was measured from donation of sample 1. All individuals included had a previous negative result in sample 1 and reported being vaccinated between sample1 and sample 2. Vaccination was wide available for people living with HIV since march 2021; all samples included in the analysis were obtained after vaccination

Back to article page

Virology Journal

ISSN: 1743-422X